NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 162 filers reported holding NEVRO CORP in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $538,160 | -24.4% | 28,000 | 0.0% | 0.17% | -14.4% |
| Q2 2023 | $711,760 | -61.0% | 28,000 | +32.0% | 0.20% | -71.6% |
| Q3 2019 | $1,823,000 | +7.3% | 21,210 | -19.1% | 0.69% | +7.4% |
| Q2 2019 | $1,699,000 | -12.9% | 26,210 | -16.0% | 0.64% | -24.1% |
| Q1 2019 | $1,951,000 | +60.7% | 31,210 | 0.0% | 0.84% | +39.4% |
| Q4 2018 | $1,214,000 | – | 31,210 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |